Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, company's strategic investment arm that includes a collection of sustainable manufacturing and technology innovation companies.

Company profile
Ticker
NUS
Exchange
Website
CEO
Ritch Wood
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
NU SKIN ASIA INC, NU SKIN ASIA PACIFIC INC, NU SKIN ENTERPRISES INC
SEC CIK
Corporate docs
Subsidiaries
Big Planet, Inc. • Corner Canyon Canada, Inc. • Corner Canyon Manufacturing, Inc. • Elevate Nutraceuticals LLC • Grōv Technologies, LLC • Grow Solutions Tech LLC • Guangdong Xingchuang Daily-Use & Health Products Co. Ltd. • Ingredient Innovations International Company • Innuvate Health Sciences LLC • L&W Holdings, Inc. ...
IRS number
870565309
NUS stock data
News

Target And 2 Other Stocks Insiders Are Selling
23 Jun 22
Nu Skin Enterprises's Return On Capital Employed Insights
17 May 22
DA Davidson Maintains Neutral on Nu Skin Enterprises, Lowers Price Target to $45
5 May 22
Recap: Nu Skin Enterprises Q1 Earnings
4 May 22
Nu Skin Enterprises Q1 EPS $0.76 Beats $0.72 Estimate, Sales $604.90M Beat $579.91M Estimate
4 May 22
Press releases
Nu Skin Kicks Off Its Global Day of Service with Projects for Children
14 Jun 22
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at Stifel Cross Sector Insight Conference
7 Jun 22
Nu Skin Joins EcoBeautyScore Consortium to Drive Industry Standard for Sustainable Beauty Products
17 May 22
Nu Skin Enterprises Reports First Quarter Financial Results
4 May 22
Nu Skin Enterprises Announces Quarterly Dividend
4 May 22
Analyst ratings and price targets
Calendar
4 May 22
2 Jul 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 302.22M | 302.22M | 302.22M | 302.22M | 302.22M | 302.22M |
Cash burn (monthly) | 12.46M | 3.07M | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 38.21M | 9.43M | n/a | n/a | n/a | n/a |
Cash remaining | 264.01M | 292.79M | n/a | n/a | n/a | n/a |
Runway (months of cash) | 21.2 | 95.3 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.02 | 2,175 | 97.92K | 20,800 |
23 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.2 | 14,954 | 675.92K | 121,699 |
22 Jun 22 | Lipman Andrew D | Class A Common Stock | Sell | Dispose S | No | Yes | 44.06 | 1,000 | 44.06K | 72,393 |
22 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.01 | 400 | 18K | 22,975 |
22 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.01 | 400 | 18K | 136,653 |
21 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.02 | 3,225 | 145.19K | 23,375 |
21 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.02 | 3,201 | 144.11K | 137,053 |
17 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.02 | 400 | 18.01K | 26,600 |
17 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45.01 | 500 | 22.51K | 140,254 |
15 Jun 22 | Steven Lund | Class A Common Stock | Sell | Dispose S | Yes | Yes | 45 | 200 | 9K | 27,000 |
Institutional ownership, Q1 2022
84.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 231 |
Opened positions | 23 |
Closed positions | 48 |
Increased positions | 85 |
Reduced positions | 82 |
13F shares | Current |
---|---|
Total value | 2.02B |
Total shares | 42.28M |
Total puts | 183.7K |
Total calls | 65.9K |
Total put/call ratio | 2.8 |
Largest owners | Shares | Value |
---|---|---|
STT State Street | 6.52M | $312.21M |
Vanguard | 6M | $287.27M |
BLK Blackrock | 5.79M | $277.28M |
Wellington Management | 3.7M | $177.22M |
Renaissance Technologies | 2.67M | $127.89M |
Dimensional Fund Advisors | 1.71M | $81.87M |
Capital World Investors | 1.1M | $52.67M |
Geode Capital Management | 898.25K | $43.01M |
BK Bank Of New York Mellon | 822.09K | $39.36M |
Aristotle Capital Boston | 803.6K | $38.48M |
Financial report summary
?Competition
MannatechRisks
- Challenges to the form of our network marketing system could harm our business.
- Laws and regulations may prohibit or severely restrict direct selling and cause our revenue and profitability to decline, and regulators could adopt new regulations that harm our business.
- Improper sales force actions could harm our business.
- Social media platforms’ decisions to prohibit, block or decrease the prominence of our sales force’s content could harm our business.
- If our business practices or policies or the actions of our sales force are deemed to be in violation of applicable local regulations regarding foreigners, then we could be sanctioned and/or required to change our business model, which could significantly harm our business.
- Our sales compensation plans or other incentives could be viewed negatively by some of our sales force, could fail to achieve desired long-term results and have a negative impact on revenue.
- Limits on the amount of sales compensation we pay could inhibit our ability to attract and retain our sales force, negatively impact our revenue and cause regulatory risks.
- We may be held responsible for certain taxes or assessments relating to the activities of our sales force, which could harm our financial condition and operating results.
- Our operations in Mainland China are subject to significant government scrutiny, and we could be subject to fines or other penalties.
- If direct selling regulations in Mainland China are modified, interpreted or enforced in a manner that results in negative changes to our business model or the imposition of a range of potential penalties, our business could be significantly negatively impacted.
- Our ability to expand our business in Mainland China could be negatively impacted if we are unable to obtain additional necessary national and local government approvals in Mainland China.
- If we are not able to register products for sale in Mainland China, our business could be harmed.
- Our markets are intensely competitive, and market conditions and the strengths of competitors may harm our business.
- Adverse publicity concerning our business, marketing plan, products or people could harm our business and reputation.
- Inability of products, platforms, business opportunities and other initiatives to gain or maintain sales force and market acceptance could harm our business.
- Product diversion may have a negative impact on our business.
- Epidemics, including COVID-19, and other crises have and may continue to negatively impact our business.
- Our ability to conduct business in international markets may be affected by political, legal, tax and regulatory risks.
- We are subject to financial risks as a result of our international operations, including exposure to foreign-currency fluctuations, currency controls and inflation in foreign markets, all of which could impact our financial position and results of operations.
- Potential changes to tariff and import/export regulations, and ongoing trade disputes between the United States and other jurisdictions may have a negative effect on global economic conditions and our business, financial results and financial condition.
- If we are unable to retain our existing sales force and recruit additional people to join our sales force, our revenue may not increase and may even decline.
- We depend on our key personnel and Sales Leaders, and the loss of the services provided by any of our executive officers, other key employees or key Sales Leaders could harm our business and results of operations.
- Production difficulties, quality control problems, inaccurate forecasting, shortages in ingredients, and reliance on our suppliers could harm our business.
- The loss of or a disruption in our manufacturing, supply chain and distribution operations, or significant expenses or violations incurred by such operations, could adversely affect our business.
- Our business could be negatively impacted if we fail to execute our product launch process or ongoing product sales due to difficulty in forecasting or increased pressure on our supply chain, information systems and management.
- If we are unable to effectively manage our growth in certain markets, our operations could be harmed.
- System failures, capacity constraints and other information technology difficulties could harm our business.
- Any acquired companies or future acquisitions may expose us to additional risks.
- Regulations governing our products, including the formulation, registration, pre-approval, marketing and sale of our products, could harm our business.
- Government regulations and private party actions relating to the marketing and advertising of our products and services may restrict, inhibit or delay our ability to sell our products and harm our business.
- Our operations could be harmed if we fail to comply with Good Manufacturing Practices.
- If our current or any future device products are determined to be medical devices in a particular geographic market, or if our sales force uses these products for medical purposes or makes improper medical claims, our ability to continue to market and distribute such devices could be harmed, and we could face legal or regulatory actions.
- We may incur product liability claims that could harm our business.
- We may become involved in legal proceedings and other matters that could adversely affect our operations or financial results.
- Non-compliance with anti-corruption laws could harm our business.
- A failure of our internal controls over financial reporting or our regulatory compliance efforts could harm our stock price and our financial and operating results or could result in fines or penalties.
- Government authorities may question our tax or customs positions or change their laws in a manner that could increase our effective tax rate or otherwise harm our business.
- We could be subject to changes in our tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities, which could have a material and adverse impact on our operating results, cash flows and financial condition.
- Transition from LIBOR to an alternative benchmark interest rate could have an adverse effect on our overall financial position.
- We may be subject to claims of infringement on the intellectual property rights or trade secrets of others, resulting in costly litigation.
- If we are unable to protect our intellectual property rights or our proprietary information and know-how, our ability to compete could be negatively impacted and the value of our products could be adversely affected.
- Cyber security risks and the failure to maintain the integrity of company, employee, sales force or guest data could expose us to data loss, litigation, liability and harm to our reputation.
- The market price of our Class A common stock is subject to significant fluctuations due to a number of factors that are beyond our control.
- Difficult economic conditions could harm our business.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accrual, backend, book, branch, bridge, ceased, commercialization, community, conflict, construction, cooperated, COVID, earned, exit, feed, fully, geopolitical, goal, hotel, Hubei, incident, insight, instituted, iO, January, learned, learning, leaving, LumiSpa, Maylasia, Ministry, momentum, month, monthly, nonrecurring, nurturing, organized, PCR, persist, population, precluded, proactively, progressed, Province, reclassification, reportedly, Reset, rest, resuming, role, sale, Shanghai, Shortly, softening, traced, Ukraine, unchanged, Wuhan
Removed:
accurately, achievement, acting, announce, Boost, broader, building, capacity, care, citizenship, cloud, continuing, criticized, detailed, developing, disposal, diversity, drove, environmental, evaluating, evolving, fail, found, governance, greater, inclusion, increasingly, Ingredient, International, investing, nutrition, pandemic, participate, payout, productivity, pursue, recent, refine, responsible, responsibly, scope, SEC, service, shared, sharing, slight, sourcing, successful, supported, sustainability, thousand, transition
Financial reports
Current reports
8-K
Entry into a Material Definitive Agreement
17 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 22
8-K
Departure of Directors or Certain Officers
2 Jun 22
8-K
Nu Skin Enterprises Reports First Quarter Financial Results
4 May 22
8-K
Regulation FD Disclosure
19 Apr 22
8-K
Nu Skin Enterprises Reports Fourth Quarter and 2021 Financial Results
16 Feb 22
8-K
Regulation FD Disclosure
5 Jan 22
8-K
Cost Associated with Exit or Disposal Activities
29 Dec 21
8-K
Nu Skin Enterprises Reports Third Quarter 2021 Results
3 Nov 21
8-K
Nu Skin Enterprises Provides Estimated Third Quarter Revenue
4 Oct 21
Registration and prospectus
S-8
Registration of securities for employees
11 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jun 20
S-8
Registration of securities for employees
3 Jun 20
S-3ASR
Automatic shelf registration
28 Feb 18
RW
Registration withdrawal request
27 Feb 18
S-3
Shelf registration
27 Feb 18
POS AM
Prospectus update (post-effective amendment)
26 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 16
Proxies
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEFA14A
Additional proxy soliciting materials
12 Apr 21
DEFA14A
Additional proxy soliciting materials
20 May 20
DEFA14A
Additional proxy soliciting materials
13 Apr 20
DEFA14A
Additional proxy soliciting materials
17 Apr 19
DEF 14A
Definitive proxy
16 Apr 18
Other
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
25 May 21
SD
Conflict minerals disclosure
19 May 20
SD
Conflict minerals disclosure
29 May 19
SD
Conflict minerals disclosure
16 May 18
SD
Conflict minerals disclosure
23 May 17
UPLOAD
Letter from SEC
1 Mar 17
CORRESP
Correspondence with SEC
23 Feb 17
CORRESP
Correspondence with SEC
2 Feb 17
CORRESP
Correspondence with SEC
19 Jan 17
Ownership
4
NU SKIN ENTERPRISES / STEVEN LUND ownership change
23 Jun 22
4
NU SKIN ENTERPRISES / ANDREW D LIPMAN ownership change
22 Jun 22
4
NU SKIN ENTERPRISES / STEVEN LUND ownership change
22 Jun 22
4
NU SKIN ENTERPRISES / STEVEN LUND ownership change
15 Jun 22
4
NU SKIN ENTERPRISES / EDWINA D WOODBURY ownership change
8 Jun 22
4
NU SKIN ENTERPRISES / Mark H Lawrence ownership change
8 Jun 22
4
NU SKIN ENTERPRISES / Chayce David Clark ownership change
6 Jun 22
4
NU SKIN ENTERPRISES / Steven Keith Hatchett ownership change
6 Jun 22
4
NU SKIN ENTERPRISES / DANIEL W CAMPBELL ownership change
2 Jun 22
4
NU SKIN ENTERPRISES / Emma S. Battle ownership change
2 Jun 22
Patents
Utility
Skin Treatment Device
5 May 22
A skin treatment device includes a roller disposed about a rotational axis, with a plurality of flexible, compressive skin contact elements distributed circumferentially about the roller.
Utility
Fingertip mounted microcurrent device for skin
3 May 22
A device for delivery of TENS current or electrostimulation has a first skin contact electrode mounted on a first non-conductive fingertip base and having at least one contact area for current-bearing contact with skin and a connection to a TENS current source and has a second skin contact electrode, mounted on a non-conductive fingertip base that is the same as the first non-conductive fingertip base or is a second non-conductive fingertip base and having at least one contact area for current-bearing contact with skin and a connection to TENS current source.
Utility
Devices, Systems, and Methods for Providing and Using One or More Valves In an Assembly Line Grow Pod
24 Mar 22
Devices, systems, and methods for providing and operating a valve control module and valves in an assembly line grow pod are provided herein.
Utility
Systems and Methods for Providing Air Flow In a Grow Pod
24 Feb 22
A controller for an air supplier of an assembly line grow pod is provided.
Utility
Systems and Methods for Managing a Weight of a Plant In a Grow Pod
20 Jan 22
An assembly line grow pod includes a seeding region, a harvesting region, a track that extends between the seeding region and the harvesting region, a cart including a tray for holding plant matter, and a wheel coupled to the tray, where the wheel is engaged with the track, and a weight sensor positioned on the cart or the track, where the weight sensor is positioned to detect a weight of the plant matter positioned within the cart.
Transcripts
2022 Q1
Earnings call transcript
5 May 22
2021 Q3
Earnings call transcript
4 Nov 21
2021 Q2
Earnings call transcript
5 Aug 21
2021 Q1
Earnings call transcript
6 May 21
2020 Q3
Earnings call transcript
4 Nov 20
2020 Q2
Earnings call transcript
5 Aug 20
2020 Q1
Earnings call transcript
6 May 20
2019 Q4
Earnings call transcript
12 Feb 20
2019 Q3
Earnings call transcript
5 Nov 19
2019 Q2
Earnings call transcript
6 Aug 19
Reddit threads
Daily Discussion Thread - May 26th, 2022
26 May 22
Daily Discussion Thread - May 25th, 2022
25 May 22
Daily Discussion Thread - May 24th, 2022
24 May 22
Daily Discussion Thread - May 23rd, 2022
23 May 22
Daily Discussion Thread - May 4th, 2022
4 May 22
Daily Discussion Thread - May 3rd, 2022
3 May 22
Daily Discussion Thread - May 2nd, 2022
2 May 22
Daily Discussion Thread - February 25th, 2022
25 Feb 22
Daily Discussion Thread - February 24th, 2022
24 Feb 22
There Won’t Be A War In Ukraine Because Russia Already Won
17 Feb 22